| Bioactivity | TAT peptide (TFA) is a cell penetrating peptide (GRKKRRQRRRPQ) derived from the trans-activating transcriptional activator (Tat) from HIV-1[1][2]. | ||||||
| Invitro | TAT peptide (TFA) is a cell penetrating peptide (GRKKRRQRRRPQ) derived from the trans-activating transcriptional activator (Tat) from HIV-1[1]. TAT peptide (TFA) (GRKKRRQRRRPQ) functionalized hybrid nanoparticles are also studied due to their combined magnetic enrichment and optical detection for cell separation and rapid cell labelling. A cell viability assay reveals good biocompatibility of these hybrid nanoparticles[2]. | ||||||
| Name | TAT peptide TFA | ||||||
| Shortening | GRKKRRQRRRPQ | ||||||
| Formula | C67H125F3N34O17 | ||||||
| Molar Mass | 1735.93 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
TAT peptide TFA
CAS: F: C67H125F3N34O17 W: 1735.93
TAT peptide (TFA) is a cell penetrating peptide (GRKKRRQRRRPQ) derived from the trans-activating transcriptional activat
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.